Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19

This analysis describes the prevalence of contraindications to nirmatrelvir/ritonavir among 66 007 patients with coronavirus disease 2019 in a large health care system. A possible contradiction was present in 9830 patients (14.8%), with the prevalence of contraindications increasing with higher acui...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sarah, Tignanelli, Christopher J, Hoertel, Nicolas, Boulware, David R, Usher, Michael G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384640/
https://www.ncbi.nlm.nih.gov/pubmed/36000003
http://dx.doi.org/10.1093/ofid/ofac389
_version_ 1784769456081207296
author Lim, Sarah
Tignanelli, Christopher J
Hoertel, Nicolas
Boulware, David R
Usher, Michael G
author_facet Lim, Sarah
Tignanelli, Christopher J
Hoertel, Nicolas
Boulware, David R
Usher, Michael G
author_sort Lim, Sarah
collection PubMed
description This analysis describes the prevalence of contraindications to nirmatrelvir/ritonavir among 66 007 patients with coronavirus disease 2019 in a large health care system. A possible contradiction was present in 9830 patients (14.8%), with the prevalence of contraindications increasing with higher acuity of illness.
format Online
Article
Text
id pubmed-9384640
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-93846402022-08-18 Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19 Lim, Sarah Tignanelli, Christopher J Hoertel, Nicolas Boulware, David R Usher, Michael G Open Forum Infect Dis Brief Report This analysis describes the prevalence of contraindications to nirmatrelvir/ritonavir among 66 007 patients with coronavirus disease 2019 in a large health care system. A possible contradiction was present in 9830 patients (14.8%), with the prevalence of contraindications increasing with higher acuity of illness. Oxford University Press 2022-08-03 /pmc/articles/PMC9384640/ /pubmed/36000003 http://dx.doi.org/10.1093/ofid/ofac389 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Report
Lim, Sarah
Tignanelli, Christopher J
Hoertel, Nicolas
Boulware, David R
Usher, Michael G
Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19
title Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19
title_full Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19
title_fullStr Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19
title_full_unstemmed Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19
title_short Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19
title_sort prevalence of medical contraindications to nirmatrelvir/ritonavir in a cohort of hospitalized and nonhospitalized patients with covid-19
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384640/
https://www.ncbi.nlm.nih.gov/pubmed/36000003
http://dx.doi.org/10.1093/ofid/ofac389
work_keys_str_mv AT limsarah prevalenceofmedicalcontraindicationstonirmatrelvirritonavirinacohortofhospitalizedandnonhospitalizedpatientswithcovid19
AT tignanellichristopherj prevalenceofmedicalcontraindicationstonirmatrelvirritonavirinacohortofhospitalizedandnonhospitalizedpatientswithcovid19
AT hoertelnicolas prevalenceofmedicalcontraindicationstonirmatrelvirritonavirinacohortofhospitalizedandnonhospitalizedpatientswithcovid19
AT boulwaredavidr prevalenceofmedicalcontraindicationstonirmatrelvirritonavirinacohortofhospitalizedandnonhospitalizedpatientswithcovid19
AT ushermichaelg prevalenceofmedicalcontraindicationstonirmatrelvirritonavirinacohortofhospitalizedandnonhospitalizedpatientswithcovid19

Ejemplares similares